This was not observed in our tumor tissues, which can be regarded as an additional marker of inflammation, as production of ASPN and DCN is suppressed by IL1β [73] and low abundance of these markers was also observed in triple-negative inflammatory breast cancer CAFs [51]. This evidence concerns the gene IL1B and neoplasm.